The Staphylococcus aureus methicillin resistance factor FmtA is a D-amino esterase that acts on teichoic acids

mBio

Volumn 7, Issue 1, 2016, Pages

  Rahman, Muhammad M ^a   Hunter, Howard N ^a   Prova, Shamina ^a   Verma, Vidhu ^a   Qamar, Aneela ^a   Golemi Kotra, Dasantila ^a  

^a YORK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BETA LACTAMASE; DEXTRO ALANINE; ESTERASE; ESTERASE FMTA; GLYCEROPHOSPHATE; PENICILLIN BINDING PROTEIN; RIBITOL; TEICHOIC ACID; UNCLASSIFIED DRUG; ALANINE; ARYLESTERASE; CARBOXYLESTERASE; FMTA PROTEIN, STAPHYLOCOCCUS AUREUS; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID;

ARTICLE; AUTOLYSIS; BACTERIAL CELL; BACTERIAL COLONIZATION; BACTERIAL MEMBRANE; BIOFILM; CELL DIVISION; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; FMTA GENE; GENE; GENE CONTROL; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; STAPHYLOCOCCUS AUREUS; BIOSYNTHESIS; CELL WALL; CHEMISTRY; ENZYMOLOGY; GENETICS; HYDROLYSIS; KINETICS; METABOLISM; PENICILLIN RESISTANCE; PROTEIN DOMAIN;

ALANINE; BETA-LACTAMASES; CARBOXYLIC ESTER HYDROLASES; CELL WALL; HYDROLYSIS; KINETICS; LIPOPOLYSACCHARIDES; METHICILLIN RESISTANCE; PENICILLIN-BINDING PROTEINS; PROTEIN INTERACTION DOMAINS AND MOTIFS; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS;

EID: 84960156023     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02070-15     Document Type: Article

References (91)

1. Lowy FD. 2003. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111:1265–1273. http://dx.doi.org/10.1172/JCI18535.
2. Holden MT, Feil EJ, Lindsay JA, Peacock SJ, Day NP, Enright MC, Foster TJ, Moore CE, Hurst L, Atkin R, Barron A, Bason N, Bentley SD, Chillingworth C, Chillingworth T, Churcher C, Clark L, Corton C, Cronin A, Doggett J. 2004. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci U S A 101:9786–9791. http://dx.doi.org/10.1073/pnas.0402521101.
3. Fitzgerald JR, Sturdevant DE, Mackie SM, Gill SR, Musser JM. 2001. Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic. Proc Natl Acad Sci U S A 98:8821–8826. http://dx.doi.org/10.1073/pnas.161098098.
4. Hiramatsu K, Cui L, Kuroda M, Ito T. 2001. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 9:486–493. http://dx.doi.org/10.1016/S0966-842X(01)02175-8.
5. Bartley J. 2002. First case of VRSA identified in Michigan. Infect Control Hosp Epidemiol 23:480.
6. Brown DFJ, Reynolds PE. 1980. Intrinsic resistance to beta-lactam antibiotics in Staphylococcus aureus. FEBS Lett 122:275–278. http://dx.doi.org/10.1016/0014-5793(80)80455-8.
7. Bancroft EA. 2007. Antimicrobial resistance—it’s not just for hospitals. JAMA 298:1803–1804.
8. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK, Active Bacterial Core surveillance (ABCs) MRSA Investigators. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763–1771. http://dx.doi.org/10.1001/jama.298.15.1763.
9. Silver LL. 2003. Novel inhibitors of bacterial cell wall synthesis. Curr Opin Microbiol 6:431–438. http://dx.doi.org/10.1016/j.mib.2003.08.004.
10. David MZ, Daum RS. 2010. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 23:616–687. http://dx.doi.org/10.1128/CMR.00081-09.
11. Walsh C. 2003. Where will new antibiotics come from? Nat Rev Microbiol 1:65–70. http://dx.doi.org/10.1038/nrmicro727.
12. Bassetti M, Merelli M, Temperoni C, Astilean A. 2013. New antibiotics for bad bugs: where are we? Ann Clin Microbiol Antimicrob 12:22. http://dx.doi.org/10.1186/1476-0711-12-22.
13. Swoboda JG, Meredith TC, Campbell J, Brown S, Suzuki T, Bollenbach T, Malhowski AJ, Kishony R, Gilmore MS, Walker S. 2009. Discovery of a small molecule that blocks wall teichoic acid biosynthesis in Staphylococcus aureus. ACS Chem Biol 4:875–883. http://dx.doi.org/10.1021/cb900151k.
14. Farha MA, Leung A, Sewell EW, D’Elia MA, Allison SE, Ejim L, Pereira PM, Pinho MG, Wright GD, Brown ED. 2013. Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to beta-lactams. ACS Chem Biol 8:226–233. http://dx.doi.org/10.1021/cb300413m.
15. Campbell J, Singh AK, Santa Maria JP, Kim Y, Brown S, Swoboda JG, Mylonakis E, Wilkinson BJ, Walker S. 2011. Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus. ACS Chem Biol 6:106–116. http://dx.doi.org/10.1021/cb100269f.
16. Blake KL, O’Neill AJ, Mengin-Lecreulx D, Henderson PJ, Bostock JM, Dunsmore CJ, Simmons KJ, Fishwick CW, Leeds JA, Chopra I. 2009. The nature of Staphylococcus aureus MurA and MurZ and approaches for detection of peptidoglycan biosynthesis inhibitors. Mol Microbiol 72: 335–343. http://dx.doi.org/10.1111/j.1365-2958.2009.06648.x.
17. Gardete S, Ludovice AM, Sobral RG, Filipe SR, de Lencastre H, Tomasz A. 2004. Role of murE in the expression of beta-lactam antibiotic resistance in Staphylococcus aureus. J Bacteriol 186:1705–1713. http://dx.doi.org/10.1128/JB.186.6.1705-1713.2004.
18. Sobral RG, Ludovice AM, de Lencastre H, Tomasz A. 2006. Role of murF in cell wall biosynthesis: isolation and characterization of a murF conditional mutant of Staphylococcus aureus. J Bacteriol 188:2543–2553. http://dx.doi.org/10.1128/JB.188.7.2543-2553.2006.
19. Balibar CJ, Shen X, Tao J. 2009. The mevalonate pathway of Staphylococcus aureus. J Bacteriol 191:851–861. http://dx.doi.org/10.1128/JB.01357-08.
20. Komatsuzawa H, Sugai M, Ohta K, Fujiwara T, Nakashima S, Suzuki J, Lee CY, Suginaka H. 1997. Cloning and characterization of the fmt gene which affects the methicillin resistance level and autolysis in the presence of Triton X-100 in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 41:2355–2361.
21. Bernal P, Lemaire S, Pinho MG, Mobashery S, Hinds J, Taylor PW. 2010. Insertion of epicatechin gallate into the cytoplasmic membrane of methicillin-resistant Staphylococcus aureus disrupts penicillinbinding protein (PBP) 2a-mediated beta-lactam resistance by delocalizing PBP2. J Biol Chem 285:24055–24065. http://dx.doi.org/10.1074/jbc.M110.114793.
22. McAleese F, Wu SW, Sieradzki K, Dunman P, Murphy E, Projan S, Tomasz A. 2006. Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycinintermediate-S. aureus-type resistance to vancomycin. J Bacteriol 188: 1120–1133. http://dx.doi.org/10.1128/JB.188.3.1120-1133.2006.
23. McCallum N, Spehar G, Bischoff M, Berger-Bächi B. 2006. Strain dependence of the cell wall-damage induced stimulon in Staphylococcus aureus. Biochim Biophys Acta 1760:1475–1481. http://dx.doi.org/10.1016/j.bbagen.2006.06.008.
24. Utaida S, Dunman PM, Macapagal D, Murphy E, Projan SJ, Singh VK, Jayaswal RK, Wilkinson BJ. 2003. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology 149:2719–2732. http://dx.doi.org/10.1099/mic.0.26426-0.
25. Fan X, Liu Y, Smith D, Konermann L, Siu KW, Golemi-Kotra D. 2007. Diversity of penicillin-binding proteins. Resistance factor FmtA of Staphylococcus aureus. J Biol Chem 282:35143–35152. http://dx.doi.org/10.1074/jbc.M706296200.
26. Qamar A, Golemi-Kotra D. 2012. Dual roles of FmtA in Staphylococcus aureus cell wall biosynthesis and autolysis. Antimicrob Agents Chemother 56:3797–3805. http://dx.doi.org/10.1128/AAC.00187-12.
27. Wada A, Watanabe H. 1998. Penicillin-binding protein 1 of Staphylococcus aureus is essential for growth. J Bacteriol 180:2759–2765.
28. Łeski TA, Tomasz A. 2005. Role of penicillin-binding protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-linking of Staphylococcus aureus: evidence for the cooperative functioning of PBP2, PBP4, and PBP2A. J Bacteriol 187:1815–1824. http://dx.doi.org/10.1128/JB.187.5.1815-1824.2005.
29. Schlag M, Biswas R, Krismer B, Kohler T, Zoll S, Yu W, Schwarz H, Peschel A, Götz F. 2010 Role of Staphylococcal wall teichoic acid in targeting the major autolysin Atl. Mol Microbiol 75:864–873.
30. Atilano ML, Pereira PM, Yates J, Reed P, Veiga H, Pinho MG, Filipe SR. 2010. Teichoic acids are temporal and spatial regulators of peptidoglycan cross-linking in Staphylococcus aureus. Proc Natl Acad Sci U S A 107: 18991–18996. http://dx.doi.org/10.1073/pnas.1004304107.
31. Brown S, Santa Maria JP, Jr., Walker S. 2013. Wall teichoic acids of Gram-positive bacteria. Annu Rev Microbiol 67:313–336. http://dx.doi.org/10.1146/annurev-micro-092412-155620.
32. Percy MG, Gründling A. 2014. Lipoteichoic acid synthesis and function in Gram-positive bacteria. Annu Rev Microbiol 68:81–100. http://dx.doi.org/10.1146/annurev-micro-091213-112949.
33. Reichmann NT, Gründling A. 2011. Location, synthesis and function of glycolipids and polyglycerolphosphate lipoteichoic acid in Gram-positive bacteria of the phylum Firmicutes. FEMS Microbiol Lett 319:97–105. http://dx.doi.org/10.1111/j.1574-6968.2011.02260.x.
34. Swoboda JG, Campbell J, Meredith TC, Walker S. 2010. Wall teichoic acid function, biosynthesis, and inhibition. Chembiochem 11:35–45. http://dx.doi.org/10.1002/cbic.200900557.
35. Koch HU, Haas R, Fischer W. 1984. The role of lipoteichoic acid biosynthesis in membrane lipid metabolism of growing Staphylococcus aureus. Eur J Biochem 138:357–363. http://dx.doi.org/10.1111/j.1432-1033.1984.tb07923.x.
36. Allison SE, D’Elia MA, Arar S, Monteiro MA, Brown ED. 2011. Studies of the genetics, function, and kinetic mechanism of TagE, the wall teichoic acid glycosyltransferase in Bacillus subtilis 168. J Biol Chem 286: 23708–23716. http://dx.doi.org/10.1074/jbc.M111.241265.
37. Brown S, Xia G, Luhachack LG, Campbell J, Meredith TC, Chen C, Winstel V, Gekeler C, Irazoqui JE, Peschel A, Walker S. 2012. Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids. Proc Natl Acad Sci U S A 109:18909–18914. http://dx.doi.org/10.1073/pnas.1209126109.
38. Perego M, Glaser P, Minutello A, Strauch MA, Leopold K, Fischer W. 1995. Incorporation of D-alanine into lipoteichoic acid and wall teichoic acid in Bacillus subtilis. Identification of genes and regulation. J Biol Chem 270:15598–15606. http://dx.doi.org/10.1074/jbc.270.26.15598.
39. Neuhaus FC, Baddiley J. 2003. A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in Gram-positive bacteria. Micro-biol Mol Biol Rev 67:686–723. http://dx.doi.org/10.1128/MMBR.67.4.686-723.2003.
40. Kovács M, Halfmann A, Fedtke I, Heintz M, Peschel A, Vollmer W, Hakenbeck R, Brückner R. 2006. A functional dlt operon, encoding proteins required for incorporation of D-alanine in teichoic acids in grampositive bacteria, confers resistance to cationic antimicrobial peptides in Streptococcus pneumoniae. J Bacteriol 188:5797–5805. http://dx.doi.org/10.1128/JB.00336-06.
41. Reichmann NT, Piçarra Cassona C, Monteiro JM, Bottomley AL, Corrigan RM, Foster SJ, Pinho MG, Gründling A. 2014. Differential localization of LTA synthesis proteins and their interaction with the cell division machinery in Staphylococcus aureus. Mol Microbiol 92:273–286. http://dx.doi.org/10.1111/mmi.12551.
42. Chatterjee AN. 1969. Use of bacteriophage-resistant mutants to study the nature of the bacteriophage receptor site of Staphylococcus aureus. J Bacteriol 98:519–527.
43. Peschel A, Vuong C, Otto M, Götz F. 2000. The D-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolytic enzymes. Antimicrob Agents Chemother 44: 2845–2847. http://dx.doi.org/10.1128/AAC.44.10.2845-2847.2000.
44. Collins LV, Kristian SA, Weidenmaier C, Faigle M, Van Kessel KP, Van Strijp JA, Götz F, Neumeister B, Peschel A. 2002. Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. J Infect Dis 186:214–219. http://dx.doi.org/10.1086/341454.
45. Weidenmaier C, Kokai-Kun JF, Kristian SA, Chanturiya T, Kalbacher H, Gross M, Nicholson G, Neumeister B, Mond JJ, Peschel A. 2004. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med 10:243–245. http://dx.doi.org/10.1038/nm991.
46. Park KH, Kurokawa K, Zheng L, Jung DJ, Tateishi K, Jin JO, Ha NC, Kang HJ, Matsushita M, Kwak JY, Takahashi K, Lee BL. 2010. Human serum mannose-binding lectin senses wall teichoic acid glycopolymer of Staphylococcus aureus, which is restricted in infancy. J Biol Chem 285: 27167–27175. http://dx.doi.org/10.1074/jbc.M110.141309.
47. Abachin E, Poyart C, Pellegrini E, Milohanic E, Fiedler F, Berche P, Trieu-Cuot P. 2002. Formation of D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol Microbiol 43: 1–14. http://dx.doi.org/10.1046/j.1365-2958.2002.02723.x.
48. Gross M, Cramton SE, Götz F, Peschel A. 2001. Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces. Infect Immun 69:3423–3426. http://dx.doi.org/10.1128/IAI.69.5.3423-3426.2001.
49. Fabretti F, Theilacker C, Baldassarri L, Kaczynski Z, Kropec A, Holst O, Huebner J. 2006. Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides. Infect Immun 74:4164–4171. http://dx.doi.org/10.1128/IAI.00111-06.
50. Steen A, Palumbo E, Deghorain M, Cocconcelli PS, Delcour J, Kuipers OP, Kok J, Buist G, Hols P. 2005. Autolysis of Lactococcus lactis is increased upon D-alanine depletion of peptidoglycan and lipoteichoic acids. J Bacteriol 187:114–124. http://dx.doi.org/10.1128/JB.187.1.114-124.2005.
51. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Götz F. 1999. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 274:8405–8410. http://dx.doi.org/10.1074/jbc.274.13.8405.
52. Winstel V, Liang C, Sanchez-Carballo P, Steglich M, Munar M, Bröker BM, Penadés JR, Nübel U, Holst O, Dandekar T, Peschel A, Xia G. 2013. Wall teichoic acid structure governs horizontal gene transfer between major bacterial pathogens. Nat Commun 4:2345. http://dx.doi.org/10.1038/ncomms3345.
53. Childs WC III, Taron DJ, Neuhaus FC. 1985. Biosynthesis of D-alanyllipoteichoic acid by Lactobacillus casei: interchain transacylation of D-alanyl ester residues. J Bacteriol 162:1191–1195.
54. Koprivnjak T, Mlakar V, Swanson L, Fournier B, Peschel A, Weiss JP. 2006. Cation-induced transcriptional regulation of the dlt operon of Staphylococcus aureus. J Bacteriol 188:3622–3630. http://dx.doi.org/10.1128/JB.188.10.3622-3630.2006.
55. Koch HU, Döker R, Fischer W. 1985. Maintenance of D-alanine ester substitution of lipoteichoic acid by reesterification in Staphylococcus aureus. J Bacteriol 164:1211–1217.
56. MacArthur AE, Archibald AR. 1984. Effect of culture pH on the D-alanine ester content of lipoteichoic acid in Staphylococcus aureus. J Bacteriol 160: 792–793.
57. Fischer W. 1988. Physiology of lipoteichoic acids in bacteria. Adv Microb Physiol 29:233–302. http://dx.doi.org/10.1016/S0065-2911(08)60349-5.
58. Pinho MG, de Lencastre H, Tomasz A. 2001. An acquired and a native penicillin-binding protein cooperate in building the cell wall of drugresistant staphylococci. Proc Natl Acad Sci U S A 98:10886–10891. http://dx.doi.org/10.1073/pnas.191260798.
59. Pinho MG, Filipe SR, de Lencastre H, Tomasz A. 2001. Complementation of the essential peptidoglycan transpeptidase function of penicillinbinding protein 2 (PBP2) by the drug resistance protein PBP2A in Staphylococcus aureus. J Bacteriol 183:6525–6531. http://dx.doi.org/10.1128/JB.183.22.6525-6531.2001.
60. Qiao Y, Lebar MD, Schirner K, Schaefer K, Tsukamoto H, Kahne D, Walker S. 2014. Detection of lipid-linked peptidoglycan precursors by exploiting an unexpected transpeptidase reaction. J Am Chem Soc 136: 14678–14681. http://dx.doi.org/10.1021/ja508147s.
61. Chahinian H, Sarda L. 2009. Distinction between esterases and lipases: comparative biochemical properties of sequence-related carboxylesterases. Protein Pept Lett 16:1149–1161. http://dx.doi.org/10.2174/092986609789071333.
62. Arnaud M, Chastanet A, Débarbouillé M. 2004. New vector for efficient allelic replacement in naturally nontransformable, low-GC-content, Gram-positive bacteria. Appl Environ Microbiol 70:6887–6891. http://dx.doi.org/10.1128/AEM.70.11.6887-6891.2004.
63. Sullivan MA, Yasbin RE, Young FE. 1984. New shuttle vectors for Bacillus subtilis and Escherichia coli which allow rapid detection of inserted fragments. Gene 29:21–26. http://dx.doi.org/10.1016/0378-1119(84)90161-6.
64. Haas R, Koch HU, Fischer W. 1984. Alanyl turnover from lipoteichoic acid to teichoic-acid in Staphylococcus aureus. FEMS Microbiol Lett 21: 27–31. http://dx.doi.org/10.1111/j.1574-6968.1984.tb00180.x.
65. Arpigny JL, Jaeger KE. 1999. Bacterial lipolytic enzymes: classification and properties. Biochem J 343:177–183. http://dx.doi.org/10.1042/bj3430177.
66. Wagner UG, Petersen EI, Schwab H, Kratky C. 2002. EstB from Burkholderia gladioli: a novel esterase with a beta-lactamase fold reveals steric factors to discriminate between esterolytic and beta-lactam cleaving activity. Protein Sci 11:467–478. http://dx.doi.org/10.1110/ps.33002.
67. Asano Y, Ito H, Dairi T, Kato Y. 1996. An alkaline D-stereospecific endopeptidase with beta-lactamase activity from Bacillus cereus. J Biol Chem 271:30256–30262. http://dx.doi.org/10.1074/jbc.271.47.30256.
68. Bourne DG, Riddles P, Jones GJ, Smith W, Blakeley RL. 2001. Characterisation of a gene cluster involved in bacterial degradation of the cyanobacterial toxin microcystin LR. Environ Toxicol 16:523–534. http://dx.doi.org/10.1002/tox.10013.
69. Delmarcelle M, Boursoit MC, Filée P, Baurin SL, Frère JM, Joris B. 2005. Specificity inversion of Ochrobactrum anthropi d-aminopeptidase to a D,D-carboxypeptidase with new penicillin binding activity by directed mutagenesis. Protein Sci 14:2296–2303. http://dx.doi.org/10.1110/ps.051475305.
70. Komeda H, Asano Y. 2000. Gene cloning, nucleotide sequencing, and purification and characterization of the D-stereospecific amino-acid amidase from Ochrobactrum anthropi SV3. Eur J Biochem 267:2028–2035. http://dx.doi.org/10.1046/j.1432-1327.2000.01208.x.
71. Okazaki S, Suzuki A, Komeda H, Yamaguchi S, Asano Y, Yamane T. 2007. Crystal structure and functional characterization of a D-stereospecific amino acid amidase from Ochrobactrum anthropi SV3, a new member of the penicillin-recognizing proteins. J Mol Biol 368:79–91. http://dx.doi.org/10.1016/j.jmb.2006.10.070.
72. Asano Y, Nakazawa A, Kato Y, Kondo K. 1989. Properties of a novel D-stereospecific aminopeptidase from Ochrobactrum anthropi. J Biol Chem 264:14233–14239.
73. Fanuel L, Thamm I, Kostanjevecki V, Samyn B, Joris B, Goffin C, Brannigan J, Van Beeumen J, Frère JM. 1999. Two new aminopeptidases from Ochrobactrum anthropi active on D-alanyl-p-nitroanilide. Cell Mol Life Sci 55:812–818. http://dx.doi.org/10.1007/s000180050334.
74. Petersen EI, Valinger G, Sölkner B, Stubenrauch G, Schwab H. 2001. A novel esterase from Burkholderia gladioli which shows high deacetylation activity on cephalosporins is related to beta-lactamases and DDpeptidases. J Biotechnol 89:11–25. http://dx.doi.org/10.1016/S0168-1656(01)00284-X.
75. Joris B, Ghuysen JM, Dive G, Renard A, Dideberg O, Charlier P, Frère JM, Kelly JA, Boyington JC, Moews PC. 1988. The active-site-serine penicillin-recognizing enzymes as members of the streptomyces R61 DDpeptidase family. Biochem J 250:313–324. http://dx.doi.org/10.1042/bj2500313.
76. Frère J, Joris B, Dideberg O, Charlier P, Ghuysen J. 1988. Penicillinrecognizing enzymes. Biochem Soc Trans 16:934–938. http://dx.doi.org/10.1042/bst0160934.
77. Cougnoux A, Gibold L, Robin F, Dubois D, Pradel N, Darfeuille-Michaud A, Dalmasso G, Delmas J, Bonnet R. 2012. Analysis of structure-function relationships in the colibactin-maturating enzyme ClbP. J Mol Biol 424:203–214. http://dx.doi.org/10.1016/j.jmb.2012.09.017.
78. Komatsuzawa H, Ohta K, Labischinski H, Sugai M, Suginaka H. 1999. Characterization of fmtA, a gene that modulates the expression of methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 43:2121–2125.
79. Zhao Y, Verma V, Belcheva A, Singh A, Fridman M, Golemi-Kotra D. 2012. Staphylococcus aureus methicillin-resistance factor fmtA is regulated by the global regulator SarA. PLoS One 7:e43998. http://dx.doi.org/10.1371/journal.pone.0043998.
80. Wolz C, Pöhlmann-Dietze P, Steinhuber A, Chien YT, Manna A, van Wamel W, Cheung A. 2000. Agr-independent regulation of fibronectinbinding protein(s) by the regulatory locus sar in Staphylococcus aureus. Mol Microbiol 36:230–243. http://dx.doi.org/10.1046/j.1365-2958.2000.01853.x.
81. Cheung AL, Bayer AS, Zhang G, Gresham H, Xiong YQ. 2004. Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus. FEMS Immunol Med Microbiol 40:1–9. http://dx.doi.org/10.1016/S0928-8244(03)00309-2.
82. Trotonda MP, Xiong YQ, Memmi G, Bayer AS, Cheung AL. 2009. Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics. J Infect Dis 199:209–218. http://dx.doi.org/10.1086/595740.
83. Boles BR, Thoendel M, Roth AJ, Horswill AR. 2010. Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS One 5:e10146. http://dx.doi.org/10.1371/journal.pone.0010146.
84. Tu Quoc PH, Genevaux P, Pajunen M, Savilahti H, Georgopoulos C, Schrenzel J, Kelley WL. 2007. Isolation and characterization of biofilm formation-defective mutants of Staphylococcus aureus Infect Immun 75: 1079–1088. http://dx.doi.org/10.1128/IAI.01143-06.
85. Bayles KW. 2007. The biological role of death and lysis in biofilm development. Nat Rev Microbiol 5:721–726. http://dx.doi.org/10.1038/nrmicro1743.
86. Mann EE, Rice KC, Boles BR, Endres JL, Ranjit D, Chandramohan L, Tsang LH, Smeltzer MS, Horswill AR, Bayles KW. 2009. Modulation of eDNA release and degradation affects Staphylococcus biofilm maturation. PLoS One 4:e5822. http://dx.doi.org/10.1371/journal.pone.0005822.
87. Reichmann NT, Cassona CP, Gründling A. 2013. Revised mechanism of D-alanine incorporation into cell wall polymers in Gram-positive bacteria. Microbioly 159:1868–1877. http://dx.doi.org/10.1099/mic.0.069898-0.
88. Xia G, Kohler, T, Peschel A. 2010. The wall teichoic acid and lipoteichoic caid polymers of Staphylococcus aureus Int J Med Microbiol 300:148–154. http://dx.doi.org/10.1016/j.ijmm.2009.10.001.
89. Biswas R, Martinez RE, Göhring N, Schlag M, Josten M, Xia G, Hegler F, Gekeler C, Gleske AK, Götz F, Sahl HG, Kappler A, Peschel A. 2012. Proton-binding capacity of Staphylococcus aureus wall teichoic acid and its role in controlling autolysin activity. PLoS One 7:e41415. http://dx.doi.org/10.1371/journal.pone.0041415.
90. Gutheil WG, Stefanova ME, Nicholas RA. 2000. Fluorescent coupled enzyme assays for D-alanine: application to penicillin-binding protein and vancomycin activity assays. Anal Biochem 287:196–202. http://dx.doi.org/10.1006/abio.2000.4835.
91. Fridman M, Williams GD, Muzamal U, Hunter H, Siu KW, Golemi-Kotra D. 2013. Two unique phosphorylation-driven signaling pathways crosstalk in Staphylococcus aureus to modulate the cell-wall charge: Stk1/Stp1 meets GraSR. Biochemistry 52:7975–7986. http://dx.doi.org/10.1021/bi401177n.